Product
Intraperitoneal Paclitaxel
1 clinical trial
1 indication
Indication
Peritoneal MesotheliomaClinical trial
Intraperitoneal Paclitaxel for Patients With Primary Malignant Peritoneal Mesothelioma - a Phase I/II Dose Escalation and Safety StudyStatus: Recruiting, Estimated PCD: 2026-02-01